Independent providers struggle in post-Mifid II research landscape

More than six months after the updated directive was implemented, its effects on research provision are becoming clearer. The good news is that buy-side research budgets seem to have stabilized; the bad news is that if you aren’t big, you probably aren’t on the receiving end of them.

As the dust settles from the implementation of second Market in Financial Instruments Directive at the beginning of this year, it is now becoming clear who the winners are likely to be: large global investment banks.

There has been a 19% year-on-year cut in research budgets among the largest European equity investors for 2018, to an average of over $8 million.

The equivalent figure of all institutions is 14%, leaving them an average external research and advisory budget of $3.8

Access intelligence that drives action

To unlock this research, enter your email to log in or enquire about access